Darryl Falzarano

University of Saskatchewan — Canada

Medicine · Health Sciences

38h-index9.5kcitations135works2.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(74), COVID-19 Clinical Research Studies(42), Viral Infections and Outbreaks Research(42), Viral Infections and Vectors(32), Viral gastroenteritis research and epidemiology(18)

Publications134 total

FGFR signaling and neddylation facilitate SARS-CoV-2 infection by modulating interferon induction and viral entry, respectively
iScience·2025Open Access
Developing Synthetic Full-Length SARS-CoV-2 cDNAs and Reporter Viruses for High-Throughput Antiviral Drug Screening
Viruses·2025Open Access
Genome-wide Screening Identifies Unique Host-Directed Drugs and Pro-viral Signalling Pathways for SARS-CoV-2
2025Open Access
Genome-wide Screening Identifies Unique Host-Directed Drugs and Pro-viral Signalling Pathways for SARS-CoV-2
2025Open Access
MERS-CoV and SARS-CoV-2 infection in diverse human lung organoid-derived cultures
Journal of Virology·2025· 6 citedOpen Access
Safety and immunogenicity of COVAC-2, a Sepivac SWE™ adjuvanted SARS-CoV-2 recombinant protein vaccine in healthy adults; a randomized controlled first-in-human dose-escalation trial
Vaccine·2025· 2 citedOpen Access
A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity
iScience·2025Open Access
A Spike-Accum bioconjugate protein vaccine confers potent SARS-CoV-2-specific immunity
iScience·2025Open Access
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced antiviral capacity
Nature Communications·2025· 2 citedOpen Access
Expanding the bat toolbox: Carollia perspicillata bat cell lines and reagents enable the characterization of viral susceptibility and innate immune responses
PLoS Biology·2025· 5 citedOpen Access
Combination therapy enhances the antiviral activity of IFN-λ against SARS-CoV-2 and MERS-CoV
Virus Research·2025· 2 citedOpen Access
Recruitment of pulmonary intravascular macrophages in SARS-CoV-2 infected hamsters
Cell and Tissue Research·2025· 1 cited
Impact of cell culture model systems on SARS-CoV-2 and MERS-CoV infection dynamics and antiviral responses
2025Open Access
Immunogenicity of virus-like particle vaccine candidates against SARS-CoV-2 infection
2025Open Access
Immunogenicity of virus-like particle vaccine candidates against SARS-CoV-2 infection
Access Microbiology·2025· 1 citedOpen Access
Safety and Immunogenicity of Covac-2, a Sepivac Swe™ Adjuvanted Sars-Cov-2 Recombinant Protein Vaccine in Healthy Adults; a Randomized Controlled First-in-Human Dose-Escalation Trial
SSRN Electronic Journal·2025Open Access
Bat-specific adaptations in interferon signaling and GBP1 contribute to enhanced viral tolerance
2024Open Access
Viral susceptibility and innate immune competency of <i>Carollia perspicillata</i> bat cells produced for virological studies
2024· 2 citedOpen Access
Studying bats using a One Health lens: bridging the gap between bat virology and disease ecology
Journal of Virology·2024· 12 citedOpen Access
Immunogenicity of virus-like particle vaccine candidates against SARS-CoV-2 infection
2024Open Access
page 1 of 7Next →

Frequent Co-authors

Heinz Feldmann(29), Emmie de Wit(15), Vincent J. Munster(14), Friederike Feldmann(12), Dana Scott(9), Trenton Bushmaker(8), David Safronetz(8), Neeltje van Doremalen(7), Thomas Hoenen(7), Joseph Prescott(7), Cynthia Martellaro(6), J. Lew(6), Allison Groseth(6), Andrea Marzi(6), Volker Gerdts(6), Atsushi Okumura(5), Magen E. Francis(5), Kyle Rosenke(5), Kathryn C. Zoon(5), Arinjay Banerjee(5)